E-GEOD-44353 - Identification of a prognostic gene expression-based signature for patients with prostate cancer treated with radical prostatectomy

Status
Released on 1 April 2013, last updated on 2 June 2014
Organism
Homo sapiens
Samples (210)
Array (1)
Protocols (6)
Description
Gene expression profiling was performed on tissue samples via a complementary DNA-mediated annealing, selection, extension, and ligation (DASL) assay (Illumina). 1536 were selected for profiling. 210 prostate cancer samples were used.Random forests classifcation was applied to the DASL data, and a set of genes was selected for further development. Total RNA was isolated from prostate cancer prostatecomy samples, purified, cDNA generated, and DASL performed.
Experiment type
transcription profiling by array 
Contacts
Mark Erlander, Yi Zhang
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-GEOD-44353.idf.txt
Sample and data relationshipE-GEOD-44353.sdrf.txt
Processed data (1)E-GEOD-44353.processed.1.zip
Array designA-GEOD-16688.adf.txt
Links